JointIQ supplement shows promise for active adults with knee discomfort

NCT ID NCT07382622

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily supplement called JointIQ (made from astragaloside) can reduce knee discomfort and improve mobility in healthy, active adults. Fifty participants took either the supplement or a placebo for 12 weeks. The goal was to see if those taking JointIQ had better knee stability, range of motion, and fewer symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for JOINT DISCOMFORT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chung Shan Medical University

    Taichung, 402, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.